Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 10Neurofibromatosis 1 9Breast Neoplasms 5Neurofibroma, Plexiform 4Lung Neoplasms 4Triple Negative Breast Neoplasms 3Neurofibrosarcoma 3Thyroid Neoplasms 2Neoplasms 2Melanoma 2Gallbladder Neoplasms 2Uveal Melanoma 1Thyroid Diseases 1Thyroid Cancer, Papillary 1Sarcoma, Kaposi 1Sarcoma 1Recurrence 1Rectal Neoplasms 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Optic Nerve Glioma 1Non-small Cell Lung Cancer Metastatic 1Neuroma, Acoustic 1Neurofibromatosis 2 1Neoplasm Metastasis 1Meningioma 1Liver Neoplasms 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Glioma 1

Interventions

Temozolomide 16Magnetic Resonance Spectroscopy 10Etoposide 9Cyclophosphamide 8Radiotherapy 7Carboplatin 7Bevacizumab 7Filgrastim 6Thiotepa 5Radiation 4Biopsy 4Azacitidine 42-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 4sargramostim 3etoposide phosphate 3Surveys and Questionnaires 3Peripheral Blood Stem Cell Transplantation 3Nivolumab 3Methotrexate 3Irinotecan 3Gadolinium DTPA 3Cisplatin 3Automobiles 3lutetium Lu 177 dotatate 2fluorodopa F 18 2alovudine 2aldesleukin 2Yoga 2Topotecan 2Thalidomide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Ependymoma × AZD 6244 × Clear all
NCT03095248 2025-04-22

SEL-TH-1601

Children's Hospital Medical Center, Cincinnati

Phase 2 Terminated
10 enrolled 9 charts
CNS

Ependymoma, Glioma, Meningioma, Neuroma, Acoustic, Neurofibromatosis 2

Data powered by HemOnc (CC BY 4.0) Colophon âš¡